Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Diabetes Technology & Therapeutics|August 24, 2004
The physiological rationale for oral insulin administrationEhud ArbitJournal of Diabetes Science and Technology|June 28, 2017
Oral Insulin Delivery in a Physiologic Context: ReviewEhud Arbit, Miriam KidronJournal of Diabetes Science and Technology|February 11, 2010
Oral insulin: the rationale for this approach and current developmentsEhud Arbit, Miriam KidronPlos One|April 18, 2013
Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot studyRoy Eldor, Ehud Arbit, Asher Corcos, et al.Journal of Diabetes Science and Technology|December 7, 2010
Novel glucagon-like peptide-1 analog delivered orally reduces postprandial glucose excursions in porcine and canine modelsRoy Eldor, Miriam Kidron, Yael Greenberg-Shushlav, et al.Thrombosis Journal|May 12, 2006
Oral heparin: status reviewEhud Arbit, Michael Goldberg, Isabel Gomez-Orellana, et al.British Journal of Clinical Pharmacology|November 20, 2014
Lessons learned from the clinical development of oral peptidesMorten Asser Karsdal, Bente Juul Riis, Nozer Mehta, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2021
Safety and Efficacy of Oral Human Parathyroid Hormone (1-34) in Hypoparathyroidism: An Open-Label StudySofia Ish-Shalom, Yoseph Caraco, Nariman Saba Khazen, et al.Pageof 1